Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L0MZ
|
|||
Former ID |
DNC007385
|
|||
Drug Name |
Bis(5-acetoxybenzo[b]furan-2-yl)methanone
|
|||
Synonyms |
CHEMBL226182; bis(5-acetoxybenzo[b]furan-2-yl)methanone
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H14O7
|
|||
Canonical SMILES |
CC(=O)OC1=CC2=C(C=C1)OC(=C2)C(=O)C3=CC4=C(O3)C=CC(=C4)OC(=O)C
|
|||
InChI |
1S/C21H14O7/c1-11(22)25-15-3-5-17-13(7-15)9-19(27-17)21(24)20-10-14-8-16(26-12(2)23)4-6-18(14)28-20/h3-10H,1-2H3
|
|||
InChIKey |
UACDZFCKAGJOFV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorg Med Chem. 2007 Mar 1;15(5):2187-97. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.